Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Debt for Equity Swap with UoM

31 Oct 2016 09:15

RNS Number : 8503N
Versarien PLC
31 October 2016
 

31 October 2016

Versarien plc("Versarien" or the "Company")

Debt for Equity Swap with UoM

Issue of Equity

 

Versarien Plc (AIM: VRS), the advanced materials engineering group is pleased to confirm that following discussions with the University of Manchester ("UoM") the Company and its subsidiary 2-DTech Limited will convert amounts due to UoM in respect of certain graphene collaboration agreements and proof of principle loans totalling £191,465 into equity of the Company. The proposed conversion of this debt will be at a price of 19.14 pence per share, and will result in the issue of 1,000,389 new ordinary shares representing 0.83 per cent. of the enlarged issued share capital.

 

UoM owns 15 per cent. of the shares of 2-DTech following Versarien's majority acquisition of 2-DTech in April 2014.

 

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

The debt for equity swap will be transacted at a price of 19.14 pence per share, a premium of 76 per cent. compared with the mid-market price of 10.875 pence per share at which the Ordinary Shares were quoted on AIM as at close of trading on 28 October 2016, the last trading day prior to announcement of the debt for equity swap.

 

Neill Ricketts, Chief Executive Officer commented on the agreement: "This deal further strengthens the relationship between the Company and UoM, the home of graphene, and we are delighted that UoM has further demonstrated its confidence in the progress Versarien is making in commercialising the graphene technology since its sale of 85% of the business to Versarien in 2014 by its willingness to accept shares at a substantial premium over the current market price."

 

Clive Rowland, CEO of the University's innovation company, UMI3, said: "As graphene applications are coming ever closer to becoming products in the market-place we continue to see our relationship with 2-DTech as being an important part of our network which forms our bridge between the 2D materials work taking place on campus and potential customers for graphene in a range of industry sectors."

 

Application for admission to trading on AIM of the 1,000,389 new Ordinary Shares being issued pursuant to the placing has been made and admission is expected to take place on 4 November 2016. The New Ordinary Shares will rank pari passu with the existing Ordinary Shares in issue.

 

In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the FCA, the Company confirms that, following the Placing, its issued share capital will comprise 119,844,003 Ordinary Shares of 1 pence each. All Ordinary Shares shall have equal voting rights and none of the Ordinary Shares are held in treasury. The total number of voting rights in the Company immediately following Admission will therefore be 119,844,003.

 

 

For further information please contact:

 

Versarien plc

www.versarien.com

Neill Ricketts - Chief Executive Officer

+44 (0) 1594 888 622

Chris Leigh - Chief Financial Officer

WHIreland (Nominated Adviser and Broker)

www.whirelandplc.com

Mike Coe / Ed Allsopp

+44 (0) 117 945 3470

IFC Advisory (Financial PR and IR)

www.investor-focus.co.uk

Tim Metcalfe / Graham Herring /

Heather Armstrong/Miles Nolan

+44 (0) 20 3053 8671

 

Notes to Editors:

About Versarien

Versarien plc (AIM:VRS), is an advanced materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries. Versarien has three subsidiaries:

Versarien Technologies Ltd owns the exclusive rights to a patent-protected additive process for creating advanced micro-porous metals targeting the thermal management industry and manufactures extruded aluminium heat sinks for the electronics and computing industries. www.versarien-technologies.co.uk

Versarien Advanced Composites Limited has been established in order to progress the commercial application of graphene-enhanced composite products.

Total Carbide Ltd, a leading manufacturer in sintered tungsten carbide for applications in arduous environments such as the oil and gas industry. www.totalcarbide.com

2-DTech Ltd., which specialises in the supply, characterisation and early stage development of graphene products. www.2-dtech.com

ACC Cyroma was established in 2002 and operates from a 45,000 square foot facility in Banbury, Oxfordshire. Using Versarien's existing graphene manufacturing capabilities, in combination with AAC Cyroma's knowledge, plant and equipment, the acquisition will provide the Group with an ability to produce graphene enhanced products for an established customer base, both domestic and international, including leading automotive OEMs. Versarien believes this will be the first dedicated graphene enhanced plastics manufacturing factory in the world.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAKDDDCBDKKKN
Date   Source Headline
9th Feb 20267:00 amRNSCancellation - Versarien Plc
6th Jan 20261:34 pmRNSAppointment of Administrators
19th Dec 20254:36 pmRNSUpdate on NOIA
19th Dec 20254:36 pmRNSUpdate on NOIA
15th Dec 20253:53 pmRNSUpdate on the Disposal of AAC Cyroma Limited
12th Dec 20257:00 amRNSUpdate on NOIA and Change of Registered Office
1st Dec 20257:30 amRNSSuspension - Versarien plc
1st Dec 20257:00 amRNSIntention to Appoint Administrators, Suspension
26th Nov 20257:00 amRNSUpdate - Proposed Disposal of the Company's Assets
31st Oct 20258:48 amRNSProposed Disposal of the Company’s Assets
29th Sep 20252:32 pmRNSCorporate Update
10th Sep 20251:00 pmRNSCorporate Update
29th Aug 20252:19 pmRNSCorporate Update
21st Aug 20257:00 amRNSStrategic Investment and Joint Venture Update
11th Aug 20257:00 amRNSCorporate Update
5th Aug 202511:03 amRNSHolding(s) in Company
29th Jul 20257:00 amRNSCorporate Update
22nd Jul 202510:55 amRNSSettlement of Legal Claims
4th Jul 20257:00 amRNS-RSouth American Polygrene™ Themoplastics Agreements
30th Jun 20253:03 pmRNSInterim Results
19th Jun 20252:34 pmRNSBuilding for Humanity – Contract Update
4th Jun 202511:49 amRNSHolding(s) in Company
2nd Jun 20252:03 pmRNSHolding(s) in Company
30th May 202510:19 amRNSHolding(s) in Company
30th May 20257:00 amRNSTotal Voting Rights
29th May 20253:29 pmRNSHolding(s) in Company
29th May 202510:20 amRNSHolding(s) in Company
27th May 202511:59 amRNSHolding(s) in Company
27th May 202511:02 amRNSHolding(s) in Company
23rd May 20259:38 amRNSHolding(s) in Company
22nd May 202511:56 amRNSHolding(s) in Company
21st May 202510:58 amRNSHolding(s) in Company
20th May 202511:11 amRNSHolding(s) in Company
14th May 20257:00 amRNSPlacing to raise £425,000
2nd May 202511:00 amRNSUpdate on Legal Claims
28th Apr 20251:04 pmRNSResult of AGM
27th Mar 20257:00 amRNSAudited Results for year ended 30 September 2024
24th Mar 202511:24 amRNSResult of General Meeting
10th Mar 20257:00 amRNS-RGraphinks™ supply agreement with Montana Química
5th Mar 20257:00 amRNSNotice of General Meeting
3rd Mar 20257:00 amRNSCompletion of Sale of Korean Assets
28th Feb 20257:00 amRNSTotal Voting Rights
27th Feb 20257:00 amRNSInnovate UK Loan Deed of Variation
10th Feb 20258:35 amRNSHolding(s) in Company
28th Jan 20252:36 pmRNSPlacing to raise £246k
30th Dec 202412:00 pmRNSUpdate on Sale of Korean Assets
13th Dec 20242:58 pmRNSHolding(s) in Company
13th Dec 202411:50 amRNSHolding(s) in Company
13th Dec 202410:11 amRNSHolding(s) in Company
13th Dec 20247:00 amRNS€804,000 Grant Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.